Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors

Comparison of predictive value of risk scores regarding the short-term and long-term prognosis of patients with acute myocardial infarction treated with primary percutaneous coronary intervention

Introduction: Primary percutaneous coronary intervention (pPCI) presents standard treatment in patients with acute myocardial infarction. In order to predict the prognosis of patients with ST segment elevation myocardial infarction (STEMI), several risk scores have been developed. Aim: Comparison of the predictive value of three validated risk scores, regarding intrahospital, short-term (30-days) and long-term (1-year) mortality among patients with a diagnosis of STEMI treated with pPCI in the Catheterization lab, Clinical Center of Serbia. Material and methods: The retrospective study included 311 consecutive patients with a diagnosis of STEMI treated with pPCI in 2017. Patients with cardiogenic shock at admission were excluded. Data were analyzed from the electronic database. For every patient the value of CADILLAC, ZWOLLE and TIMI score was calculated. The predictive ability of the risk scores was compared by area under (AUC) the ROC (Receiver Operating Characteristic) curves. The short-term and long-term outcome of the patient was assessed by telephone and clinical contact. Results: The study population was 311 patients, with an average age of 61±10 years, of which 237 (76.2%) were male. Rates of intrahospital, mortality at 30 days and at one year after pPCI were 1.9%, 3.2%, 6.1%. All three test scores showed very good predictive value in short-term mortality, both intrahospital (0.962; 0.986; 0.964, p=ns within scores) and after 30 days (0.920; 0.956; 0.861, p=ns within scores), while after 1 year accuracy of CADILLAC and ZWOLLE was better than TIMI score (0.921; 0.905; 0.786, p vs. TIMI 0,0087 and 0,0567). The age, three-vessel coronary disease and lower admission hemoglobin were identified as independent predictors for one-year mortality by logistic regression analysis. Conclusion: Both CADILLAC and ZWOLLE showed a very good predictive ability for intrahospital, short and long-term mortality, while for TIMI score, comparable accuracy was observed only for a period of up to 30 days following pPCI.

Impact of Multivessel Coronary Artery Disease on Long Term Prognosis in Patients with ST-segment Elevation Myocardial Infarction

Background: A significant proportion of patients with ST-segment elevation myocardial infarction (STEMI) have multivessel coronary artery disease (MVD), and they are at high risk for recurrent cardiac events. The aim of the present study was to analyze the impact of MVD on long-term cardiovascular mortality in STEMI patients treated with primary percutaneous coronary intervention (pPCI). Method: This study included 3,115 consecutive STEMI patients hospitalized in the Coronary Care Unit of the Clinical Centre of Serbia, between November 2005 and January 2012. Patients were divided in two groups: MVD and no MVD. MVD disease was defined as stenosis greater than 50% by visual assessment in more than one major coronary artery. Primary PCI was limited to the infarct-related artery (IRA). Cardiovascular mortality was defined as any death from cardiovascular reason (myocardial reinfarction, low-output heart failure, and sudden death). Patients presenting with cardiogenic shock were excluded. Patients were followed-up for 6 years after enrollment. Results: Among 3,115 analyzed patients, 1,352 (43.4%) patients had no MVD and 1,763 (56.6%) had MVD; among patients with MVD, 926 (52.6%) had two-vessel disease and 837 (47.4%) had three-vessel disease. Compared with patients with single-vessel disease, patients with MVD were older, had longer pain duration, and presented more often with heart failure; they were more likely to have previous coronary artery disease, diabetes, hypertension, and chronic kidney disease; post-procedural flow TIMI <3 was more frequently observed in patients with MVD than in patients with no MVD (5.9% vs. 3.1%, p <0.001). Patients with MVD had lower left ventricular ejection fraction than patients with single-vessel disease: 45% (interquartile range [IQR] 40¬–55%) vs. 50% (IQR 43–55%), p <0.001. Revascularization of non-IRA lesions was performed at index hospitalization in 1,075 (61%) patients, and in 602 (34.1%) patients revascularization was performed in the first few months after pPCI (median 1.5 months, IQR 1–2.5 months); coronary artery bypass grafting was performed in 291 (18.4%) patients and PCI (with stent implantation) in 1,368 (81.6%) patients. Six-year cardiovascular mortality was significantly higher in patients with MVD than in patients with single-vessel disease (10.4% vs. 4.6%, p <0.001). In multivariate Cox regression analysis, MVD remained an independent predictor for 6-year cardiovascular mortality (HR 1.55, 95% CI 1.11–2.06, p = 0.041). Conclusion: In STEMI patients treated with pPCI, the presence of MVD remained an independent predictor for higher long-term cardiovascular mortality despite early revascularization of the remaining stenosis in non-IRA.

Predictors and prognosis for incident in-hospital heart failure in patients with preserved ejection fraction after first acute myocardial infarction: An observational study

Patients with acute myocardial infarction (AMI) complicated by heart failure with preserved ejection fraction (HFpEF) are likely to have more adverse cardiovascular events and higher mortality. The purpose of this study was to examine the predictors and outcomes in AMI patients complicated by HFpEF.We examined the demographics, clinical data, and clinical outcomes in 405 consecutive subjects who firstly presented with AMI after undergoing emergency percutaneous coronary intervention from January 2013 to June 2016.Three hundred twenty patients and eighty-five patients were classified into the nonheart failure (non-HF) group and HFpEF group, respectively. Patients with HFpEF had higher prevalence of prior hypertension, had higher levels of biomarkers, and had a larger left atrial diameter with a nondilated left ventricle were more likely to develop multivessel disease-vessels and had infarction-related artery located in left anterior descending artery than patients without HF. Moreover, patients with HFpEF had a higher probability of developing the in-hospital incident cardiovascular complications and death than non-HF patients.Two routine biomarkers, levels of hypersensitive C-reactive protein and N-terminal-pro brain natriuretic peptide, and number of diseased-vessels were independent predictors for in-hospital HFpEF incidence in AMI patients with preserved LVEF. AMI patients with HFpEF had a higher probability of in-hospital cardiovascular outcomes and mortality.